Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
CREATION-P
Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)
1 other identifier
observational
80
1 country
1
Brief Summary
Cardiovascular \& echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 11, 2010
CompletedFirst Posted
Study publicly available on registry
February 12, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedFebruary 12, 2020
February 1, 2020
3 years
February 11, 2010
February 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment
1 year
Secondary Outcomes (1)
Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women
1 Year
Study Arms (3)
Control, normotensive, pregnancy
Control, normotensive, pregnancy
hypertension, pregnancy, no treatment
hypertension, pregnancy, no treatment
hypertension, pregnancy, drug treatment
hypertension, pregnancy, drug treatment
Eligibility Criteria
Pregnant Women
You may qualify if:
- hypertension during pregnancy: Chronic or pregnancy induced
You may not qualify if:
- Inability to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ha'Emek Medical Center
Afula, 18101, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Limor I Bushari
Heart Institute, Ha'Emek Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 11, 2010
First Posted
February 12, 2010
Study Start
June 1, 2009
Primary Completion
June 1, 2012
Study Completion
September 1, 2012
Last Updated
February 12, 2020
Record last verified: 2020-02